Skip to main content
Erschienen in: Surgical Endoscopy 9/2006

01.09.2006

Effect of acidosis on expression of mesothelial cell plasminogen activator inhibitor type-1

verfasst von: M. Bergström, P. Falk, L. Holmdahl

Erschienen in: Surgical Endoscopy | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Abdominal mesothelial cells are exposed to carbon dioxide during laparoscopy. Previous data indicate that carbon dioxide increases release and expression of plasminogen activator inhibitor type-1 (PAI-1) and induces acidification.

Methods

To assess the impact resulting from a range of pH, human mesothelial cells were exposed to culturing media balanced to pH levels of 6.0 to 8.0 for 90 min. Samples from cell media were withdrawn at several time points. Concentrations of PAI-1 and PAI-1 activity were measured using enzyme-linked immunoassay techniques. To focus on the effect of clinically relevant pH, cells were subjected to pH 6.4 and 7.4. Samples were withdrawn for PAI-1 assessments and for PAI-1 mRNA analyses.

Results

During exposure to various levels of pH, PAI-1 secretion and activity were variable. However, 5 h after exposure, greater concentration and activity of PAI-1 were observed in acidified cultures. More PAI-1 mRNA was isolated after exposure of cells to a pH of 6.4, apparently indicating transcriptional regulation.

Conclusions

Mesothelial cells seem to respond to acidification by an increased release and production of PAI-1 in vitro.
Literatur
1.
Zurück zum Zitat Aitola P, Airo I, Kaukinen S Ylitalo P (1998) Comparison of N2O and CO2 pneumoperitoneums during laparoscopic cholecystectomy with special reference to postoperative pain. Surg Laparosc Endosc 8: 140–144PubMedCrossRef Aitola P, Airo I, Kaukinen S Ylitalo P (1998) Comparison of N2O and CO2 pneumoperitoneums during laparoscopic cholecystectomy with special reference to postoperative pain. Surg Laparosc Endosc 8: 140–144PubMedCrossRef
2.
Zurück zum Zitat Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923–928PubMedCrossRef Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923–928PubMedCrossRef
3.
Zurück zum Zitat Bergstrom M, Falk P, Holmdahl L (2003) CO2 promotes plasminogen activator inhibitor type 1 expression in human mesothelial cells. Surg Endosc 17: 1818–1822PubMedCrossRef Bergstrom M, Falk P, Holmdahl L (2003) CO2 promotes plasminogen activator inhibitor type 1 expression in human mesothelial cells. Surg Endosc 17: 1818–1822PubMedCrossRef
4.
Zurück zum Zitat Bergstrom M, Ivarsson Ml, Holmdahl L (2002) Peritoneal response to pneumoperitoneum and laparoscopic surgery. Br J Surg 89: 1465–1469PubMedCrossRef Bergstrom M, Ivarsson Ml, Holmdahl L (2002) Peritoneal response to pneumoperitoneum and laparoscopic surgery. Br J Surg 89: 1465–1469PubMedCrossRef
5.
Zurück zum Zitat Brooks TD, Slomp J, Quax PH, De Bart AC, Spencer MT, Verheijen JH, Charlton PA (2000) Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro. Clin Exp Metastasis 18: 445–453PubMedCrossRef Brooks TD, Slomp J, Quax PH, De Bart AC, Spencer MT, Verheijen JH, Charlton PA (2000) Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro. Clin Exp Metastasis 18: 445–453PubMedCrossRef
6.
Zurück zum Zitat Duron JJ, Hay JM, Msika S, Gaschard D, Domergue J, Gainant A, Finerhut A (2000) Prevalence and mechanisms of small intestinal obstruction following laparoscopic abdominal surgery: a retrospective multicenter study. Arch Surg 135: 208–212PubMedCrossRef Duron JJ, Hay JM, Msika S, Gaschard D, Domergue J, Gainant A, Finerhut A (2000) Prevalence and mechanisms of small intestinal obstruction following laparoscopic abdominal surgery: a retrospective multicenter study. Arch Surg 135: 208–212PubMedCrossRef
7.
Zurück zum Zitat Falk K, Björkqvist P, Strömqvist M, Holmdahl L (2001) Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br J Surg 88: 286–289PubMedCrossRef Falk K, Björkqvist P, Strömqvist M, Holmdahl L (2001) Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br J Surg 88: 286–289PubMedCrossRef
8.
Zurück zum Zitat Falk P, Ma C, Chegini N, Holmdahl L (2000) Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scand J Clin Lab Invest 60: 439–447PubMedCrossRef Falk P, Ma C, Chegini N, Holmdahl L (2000) Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scand J Clin Lab Invest 60: 439–447PubMedCrossRef
9.
Zurück zum Zitat Gutt CN, Oniu T, Schemmer P, Mehrabi A, Buchler MW (2004) Fewer adhesions induced by laparoscopic surgery? Surg Endosc 18: 898–906PubMedCrossRef Gutt CN, Oniu T, Schemmer P, Mehrabi A, Buchler MW (2004) Fewer adhesions induced by laparoscopic surgery? Surg Endosc 18: 898–906PubMedCrossRef
10.
Zurück zum Zitat Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T (2003) Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an upregulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 278: 26793–26802PubMedCrossRef Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Terao T (2003) Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an upregulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 278: 26793–26802PubMedCrossRef
11.
Zurück zum Zitat Holmdahl L, Eriksson E Risberg B (1996) Fibrinolysis in human peritoneum during operation. Surgery 119: 701–705PubMedCrossRef Holmdahl L, Eriksson E Risberg B (1996) Fibrinolysis in human peritoneum during operation. Surgery 119: 701–705PubMedCrossRef
12.
Zurück zum Zitat Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B (1998) Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 58: 195–203PubMedCrossRef Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B (1998) Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 58: 195–203PubMedCrossRef
13.
Zurück zum Zitat Jacobi CA, Bonjer HJ, Puttick MI, O’Sullivan R, Lee SW, Schwalbach P, Tomita H, Kim ZG, Hewett P, Wittich P, Fleshman JW, Paraskeva P, Gessman J, Neuhaus SJ, Wildbrett P, Reymond MA, Gutt C, Whelan RI (2002) Oncologic implications of laparoscopic and open surgery. Surg Endosc 16: 441–445PubMedCrossRef Jacobi CA, Bonjer HJ, Puttick MI, O’Sullivan R, Lee SW, Schwalbach P, Tomita H, Kim ZG, Hewett P, Wittich P, Fleshman JW, Paraskeva P, Gessman J, Neuhaus SJ, Wildbrett P, Reymond MA, Gutt C, Whelan RI (2002) Oncologic implications of laparoscopic and open surgery. Surg Endosc 16: 441–445PubMedCrossRef
14.
Zurück zum Zitat Mcmahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276: 33964–33968PubMedCrossRef Mcmahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276: 33964–33968PubMedCrossRef
15.
Zurück zum Zitat Neuhaus SJ, Ellis T, Rofe AM, Pike GK, Jamieson GG, Watson DI (1998) Tumor implantation following laparoscopy using different insufflation gases. Surg Endosc 12: 1300–1302PubMedCrossRef Neuhaus SJ, Ellis T, Rofe AM, Pike GK, Jamieson GG, Watson DI (1998) Tumor implantation following laparoscopy using different insufflation gases. Surg Endosc 12: 1300–1302PubMedCrossRef
16.
Zurück zum Zitat Neuhaus SJ, Ellis TS, Barrett MW, Rofe AM, Jamieson GG, Watson DI (1999) In vitro inhibition of tumour growth in a helium-rich environment: implications for laparoscopic surgery. Aust N Z J Surg 69: 52–55PubMedCrossRef Neuhaus SJ, Ellis TS, Barrett MW, Rofe AM, Jamieson GG, Watson DI (1999) In vitro inhibition of tumour growth in a helium-rich environment: implications for laparoscopic surgery. Aust N Z J Surg 69: 52–55PubMedCrossRef
17.
Zurück zum Zitat Neuhaus SJ, Watson DI, Ellis T, Lafullarde T, Jamieson GG, Russell WJ (2001) Metabolic and immunologic consequences of laparoscopy with helium or carbon dioxide insufflation: a randomized clinical study. ANZ J Surg 71: 447–452PubMedCrossRef Neuhaus SJ, Watson DI, Ellis T, Lafullarde T, Jamieson GG, Russell WJ (2001) Metabolic and immunologic consequences of laparoscopy with helium or carbon dioxide insufflation: a randomized clinical study. ANZ J Surg 71: 447–452PubMedCrossRef
18.
Zurück zum Zitat Sui GC, Mangs H Wiman B (1999) The role of His (143) for the pH-dependent stability of plasminogen activator inhibitor-1. Biochim Biophys Acta 1434: 58–63PubMed Sui GC, Mangs H Wiman B (1999) The role of His (143) for the pH-dependent stability of plasminogen activator inhibitor-1. Biochim Biophys Acta 1434: 58–63PubMed
19.
Zurück zum Zitat Volz J, Koster S, Spacek Z, Paweletz N (1999) Characteristic alterations of the peritoneum after carbon dioxide pneumoperitoneum. Surg Endosc 13: 611–614PubMedCrossRef Volz J, Koster S, Spacek Z, Paweletz N (1999) Characteristic alterations of the peritoneum after carbon dioxide pneumoperitoneum. Surg Endosc 13: 611–614PubMedCrossRef
20.
Zurück zum Zitat Wong YT, Shah PC, Birkett DH, Brams DM (2004) Peritoneal pH during laparoscopy is dependent on ambient gas environment: helium and nitrous oxide do not cause peritoneal acidosis. Surg Endosc 19: 60–64PubMedCrossRef Wong YT, Shah PC, Birkett DH, Brams DM (2004) Peritoneal pH during laparoscopy is dependent on ambient gas environment: helium and nitrous oxide do not cause peritoneal acidosis. Surg Endosc 19: 60–64PubMedCrossRef
Metadaten
Titel
Effect of acidosis on expression of mesothelial cell plasminogen activator inhibitor type-1
verfasst von
M. Bergström
P. Falk
L. Holmdahl
Publikationsdatum
01.09.2006
Erschienen in
Surgical Endoscopy / Ausgabe 9/2006
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-005-0283-6

Weitere Artikel der Ausgabe 9/2006

Surgical Endoscopy 9/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.